Repertoire Immune Medicines
MA - CambridgeBiotechnology
Focus: Repertoire Immune Medicines is a Cambridge-based biotechnology company focused on cell and peptide-based immunotherapies targeting oncology. The company is at an early clinical stage with a pipeline of cellular and peptide candidates.
Profile data last refreshed 18h ago · AI intelligence enriched 3w ago
Open Jobs
2-2 this month
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Should You Work at Repertoire Immune Medicines?
AI assessmentBest suited for early-career scientists or clinical professionals seeking foundational platform-building experience; unsuitable for those prioritizing near-term job security or rapid career advancement.
Why Work Here
- Early-stage opportunity in emerging cell and peptide immunotherapy modalities with potential to shape foundational IP and science.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Tumor Profiling
Head and Neck CancerClinical Trials (1)
NCT05061940This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
N/AHelp build intelligence for Repertoire Immune Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.